Detection of SARS-CoV-2 neutralizing antibodies with a cell-free PCR assay

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has led to more than 4 million confirmed infections worldwide and over 300,000 deaths. While Remdesivir has recently received FDA emergency use authorization for treatment of SARS-CoV-2 infection, convalescent plasma (CP) with high titers...

詳細記述

保存先:
書誌詳細
出版年:medRxiv
主要な著者: Danh, Kenneth, Karp, Donna Grace, Robinson, Peter V., Seftel, David, Stone, Mars, Simmons, Graham, Bagri, Anil, Schreiber, Martin, Buser, Andreas, Holbro, Andreas, Battegay, Manuel, Corash, Laurence M., Hanson, Carl, Tsai, Cheng-ting
フォーマット: Artigo
言語:Inglês
出版事項: Cold Spring Harbor Laboratory 2020
主題:
Article
オンライン･アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC7302305/
https://ncbi.nlm.nih.gov/pubmed/32577696
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1101/2020.05.28.20105692
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料